Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Dziusmikeyeva, L. Surkova (Minsk, Belarus). Estimation of reparative processes intensity at MDR lung tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 4122

Member's Comments

No comment yet.

Related content which might interest you: Dynamics of morphological changes at multi drug resistant experimental lung tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 663s Year: 2007 Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Effectiveness of partial lung resection at multi-drug resistance of tuberculosis mycobacteria Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Drug concentration in lung tissue in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 42: 1750-1752 Year: 2013 Pulmonary tuberculosis and lung cancer: simultaneous and sequential occurrence Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018 The coexistence of lung cancer and pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003 Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Immunological differences between lung tuberculosis and latent tuberculosis infection Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Different antimycobacterial activity of macrophages in various lung tuberculosis legions of patients Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Metabolism of connective tissue in multidrug-resistant pulmonary tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 The treatment of a destructive lung tuberculosis by valvular lung volume reduction on early terms of therapy Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Role of mononuclear phagocytes in healing of experimental tuberculosis with multidrug resistance Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005 Understanding the mechanisms and time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 559s Year: 2005 Mycobacterium tuberculosis shape and size variations in alveolar macrophages of tuberculosis patients Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Does aging make alterations in pulmonary tuberculosis? Source: Annual Congress 2003 - Clinical aspects of tuberculosis Year: 2003 Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 489s Year: 2005